Rosiglitazone use persistent and varied in the US, despite warnings

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1330, 2010-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Restrictions on rosiglitazone use come into force in the US

By  

Reactions Weekly, Vol. 1, Iss. 1353, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The use of selective serotonin reuptake inhibitors (SSRIs) in paediatric patients has not declined "despite warnings from regulatory authorities"

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 494, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics still being prescribed, despite warnings

By  

Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics still being prescribed, despite warnings

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 478, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Labelled warnings for cisapride strengthened in the US

By  

Inpharma, Vol. 1, Iss. 1222, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite